Estimates Revisions Charles River Laboratories International, Inc. Deutsche Boerse AG
Stocks
RV6
US1598641074
Biotechnology & Medical Research
|
Real-time Estimate
Tradegate
12:05:55 2026-09-08 pm EDT
|
5-day change | 1st Jan Change | ||
| 243.95 EUR | -1.39% |
|
-1.13% | +42.51% |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
Charles River Laboratories International, Inc.(CRL)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
Charles River Laboratories International, Inc.(CRL)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
Charles River Laboratories International, Inc.(CRL)
EBIT
Dividend / Share (DPS)
Data source:
Charles River Laboratories International, Inc.(CRL)
Cash or Net Debt
Select your edition
All financial news and data tailored to specific country editions
